BRAIN Biotech AG and Formo Bio GmbH launched a strategic collaboration to further advance the production of animal-free milk proteins. BRAIN Biotech is a leading industrial biotechnology company, Formo is a pioneering food-tech startup in the space of alternative milk protein. As experts in their field, the two German biotech companies are powering European innovation.
Finnish company UPM takes the next transformative growth step and enters the biochemicals business by investing in a biorefinery at Leuna, Germany. The biorefinery will produce a range of 100% wood-based biochemicals which enable a switch from fossil raw materials to sustainable alternatives in various consumer-driven end-uses. The investment opens totally new markets for UPM with large growth potential for the future.
The BRAIN Group announced an expansion of its production capacities. The installation of new production facilities in both Büttelborn, near Darmstadt, Germany, by WeissBioTech GmbH (WBT) and in Cardiff, Wales, by Biocatalysts Ltd. lays the foundation for future growth.
The companies of the BRAIN Group form a closely knit network in the fields of R&D and production or as suppliers in specific markets. Drawing on the particular competencies of its subsidiaries, BRAIN brings its own innovative research results to market launch and commercializes existing products. By expanding its production capacities, BRAIN reinforces the strategic focus on its product business.
“Innovation is the key for the transformation towards a bioeconomy, and industrial biotechnology is the driving force and innovation engine for this megatrend”. Jürgen Eck, CEO BRAIN AG, talks with Il Bioeconomista. In this exclusive interview, the Most Innovative Bioeconomy CEO 2018 voted by our readers, talks about his company, the bioeconomy and the concept of innovation.
Finnish pulp and paper giant UPM moves forward with the development of biochemicals business by evaluating the potential of building a biorefinery in the Chemical Park Frankfurt-Höchst in Germany. The new-to-the-world biorefinery would combine novel technologies and utilize sustainable wood raw material in an innovative way. This opportunity is the outcome of more than five years of extensive technology development and piloting.
“People need to know that bioeconomy is not just an abstract concept. What we need is a coherent narrative with clear explanations of what bioeconomy is, and how it can contribute to a more sustainable way of living”. To say it, in this exclusive interview with Il Bioeconomista, is Boris Mannhardt, CEO of BIOCOM AG, an information specialist for biotechnology and Life Sciences that provides markedly diverse products and services Boris Mannhardt joined BIOCOM in 2007 and established the service business unit there. Previously he spent more than 6 years in seed and start-up financing of biotechnology companies. He holds a degree in molecular biology and did his PhD thesis at the German Cancer Research Center. He talk with us about information and education on bioeconomy, presenting also the exhibition “Bioeconomy in everyday life”.